{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-032591","form_type":"8-K","ticker":"PALI","cik":"0001357459","company_name":"PALISADE BIO, INC.","filed_at":"2022-11-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.311905+00:00","generated_at":"2026-06-21T17:20:48.135465+00:00","sec_items":["5.03","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Palisade Bio effects 1-for-50 reverse stock split to meet Nasdaq minimum bid price","bullets":["Reverse split effective 5:00 p.m. ET Nov 15, 2022; common stock trades on split-adjusted basis from Nov 16 under same ticker PALI.","Outstanding shares reduced from ~77.08M to ~1.54M; authorized shares decreased from 300M to 280M.","Split intended to raise per-share price above $1 to regain compliance with Nasdaq minimum bid-price listing requirement.","No fractional shares issued; cash paid in lieu based on Nov 15 closing price.","Conversion price of Series A Convertible Preferred Stock proportionately adjusted following the reverse split."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-032591","json":"https://secwatch.observer/filing/0001493152-22-032591.json","markdown":"https://secwatch.observer/filing/0001493152-22-032591.md","text":"https://secwatch.observer/filing/0001493152-22-032591.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357459/000149315222032591/0001493152-22-032591-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357459/000149315222032591/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T17:20:48.135465+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c56f9b64686f7d0f50a3a14ce99a6ad9bb079df7","claim":"PALISADE BIO, INC.: Amendment to certificate of incorporation to effect a 1-for-50 reverse stock split and reduce authorized shares of common stock from 300,000,000 to 280,000,000 (effective 2022-11-15).","evidence_excerpt":"On November 14, 2022, the Company filed an amendment to its amended and restated certificate of incorporation (“Amendment”) with the Secretary of State of Delaware with such Amendment becoming effective at 5:00 p.m. Eastern Time on Tuesday November 15, 2022. The purpose of the Amendment is to (i) effect the Reverse Stock Split and (ii) complete the Authorized Share Reduction.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315222032591/0001493152-22-032591-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2022-11-15"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}